In this paper, we discuss the existence and non-existence of weak solutions to the non-linear problem with a fractional p-Laplacian introduced by the ψ-Hilfer fractional operator, by combining the technique of Nehari manifolds and fibering maps. Also, we obtain some results on the ψ-Hilfer fractional operator and the Nehari manifold via the Euler functional.
The paper deals with the following Kirchhoff‐type problem
M()∬ℝ2N1pfalse(x,yfalse)false|vfalse(xfalse)−vfalse(yfalse)false|pfalse(x,yfalse)false|x−yfalse|N+pfalse(x,yfalse)sfalse(x,yfalse)dxdyfalse(−normalΔfalse)pfalse(·false)sfalse(·false)vfalse(xfalse)=μgfalse(x,vfalse)+false|vfalse|rfalse(xfalse)−2vin0.1em0.1emnormalΩ,v=0in0.1em0.1emℝN\normalΩ,
where M models a Kirchhoff coefficient,
false(−normalΔfalse)pfalse(·false)sfalse(·false) is a variable s(·)‐order p(·)‐fractional Laplace operator, with
sfalse(·false):ℝ2N→false(0,1false) and
pfalse(·false):ℝ2N→false(1,∞false). Here,
normalΩ⊂ℝN is a bounded smooth domain with N > p(x, y)s(x, y) for any
false(x,yfalse)∈truenormalΩ¯×truenormalΩ¯, μ is a positive parameter, g is a continuous and subcritical function, while variable exponent r(x) could be close to the critical exponent
ps∗false(xfalse)=Ntruep¯false(xfalse)false/false(N−trues¯false(xfalse)truep¯false(xfalse)false), given with
truep¯false(xfalse)=pfalse(x,xfalse) and
trues¯false(xfalse)=sfalse(x,xfalse) for
x∈truenormalΩ¯. We prove the existence and asymptotic behavior of at least one non‐trivial solution. For this, we exploit a suitable tricky step analysis of the critical mountain pass level, combined with a Brézis and Lieb‐type lemma for fractional Sobolev spaces with variable order and variable exponent.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.